Earnings Releases·Nov 4, 2026, 4:15 PM ET

Ardent Health — Third Quarter 2026 Earnings Summary

Total revenue rose 3.1% year-over-year to $1.625 billion, while net income turned positive at $45 million ($0.31/share) compared to a $23 million loss in the prior year period; Adjusted EBITDA margin expanded to 8.5% from 2.9% year-over-year.
Management raised full-year 2026 Adjusted EBITDA guidance midpoint to $500 million–$535 million and revised Net Income guidance to $132 million–$167 million, while reaffirming total revenue guidance of $6.4 billion–$6.7 billion.
The company executed a $25 million increase to its share repurchase program and repurchased 1.0 million shares for $11 million in the quarter, alongside a definitive agreement to transition full ownership of a Kansas hospital to a joint venture partner.
Adjusted admissions grew 2.9% year-over-year, accelerating from the previous quarter, while operating cash flow reached $122 million for the quarter and salaries as a percentage of revenue decreased to 39.9%.